Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 43, 1961-1965, May 1, 1983]
© 1983 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hirst, D. G.
Right arrow Articles by Hazlehurst, J. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hirst, D. G.
Right arrow Articles by Hazlehurst, J. L.

Effect of Partition Coefficient on the Ability of Nitroimidazoles to Enhance the Cytotoxicity of 1-(2-Chloroethyl)-3-cyclohexyl-1-nitrosourea1

David G. Hirst2, J. Martin Brown and Judith L. Hazlehurst

Department of Radiology, Stanford University School of Medicine, Stanford, California 94305

The ability of three nitroimidazoles [SR-2508, misonidazole (MISO), and benznidazole] with differing octanol-water partition coefficients to enhance the cytotoxicity of the nitrosourea 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU) was evaluated in two mouse tumors (the KHT sarcoma and the SCC VII/St carcinoma). These results were compared with the effect on two normal tissues (bone marrow CFU-S and testis spermatogonia).

When given as a large single dose, benznidazole was more effective than MISO in enhancing the cytotoxicity of CCNU to both tumors. SR-2508 had no effect. The advantage of benznidazole over MISO was lost, however, because benznidazole gave more toxicity in the normal tissues than MISO.

In experiments where the nitroimidazoles were administered by multiple small injections to maintain a blood plasma level between 50 and 100 µg/ml, benznidazole was also more effective than MISO in enhancing CCNU cytotoxicity in the tumors. In each case, enhancement was rather less than that obtained with large single injections. Again, however, benznidazole did not produce a consistently greater therapeutic gain than MISO because it also enhanced normal tissue toxicity while MISO did not. SR-2508 was ineffective in both tumors and normal tissues.

We conclude that neither SR-2508 nor benznidazole are superior to MISO in combination with CCNU.

1 This work was supported by Grants CA-15201 and CA-25990 from the National Cancer Institute, Department of Health and Human Services.

2 To whom requests for reprints should be addressed.

Received 6/30/82. Accepted 1/14/83.




This article has been cited by other articles:


Home page
Cancer Res.Home page
B. G. Wouters, Y. M. Delahoussaye, J. W. Evans, G. W. Birrell, M. J. Dorie, J. Wang, D. MacDermed, R. K. Chiu, and J. M. Brown
Mitochondrial Dysfunction after Aerobic Exposure to the Hypoxic Cytotoxin Tirapazamine
Cancer Res., January 1, 2001; 61(1): 145 - 152.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1983 by the American Association for Cancer Research.